Detalhe da pesquisa
1.
Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial.
J Urol
; 207(1): 61-69, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34433303
2.
Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report.
J Urol
; 207(4): 779-788, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34915741
3.
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial.
Lancet Oncol
; 21(6): 776-785, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32631491
4.
Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial.
Clin Infect Dis
; 69(11): 1856-1867, 2019 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30722059
6.
Erratum to: Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial.
Clin Infect Dis
; 70(11): 2459, 2020 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31626688
7.
Complications Associated With Ureteroscopic Management of Upper Tract Urothelial Carcinoma.
Urology
; 147: 87-95, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33031842
8.
Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinoma.
Cancer Chemother Pharmacol
; 87(6): 799-805, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33677615
9.
Pharmacokinetics of dalbavancin in patients with renal or hepatic impairment.
J Clin Pharmacol
; 49(4): 465-76, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19318696
10.
Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens.
Clin Infect Dis
; 40(3): 374-80, 2005 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15668859
11.
Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections.
Clin Infect Dis
; 41(10): 1407-15, 2005 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16231250
12.
Once-weekly dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections.
Clin Infect Dis
; 37(10): 1298-303, 2003 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14583862
13.
Short treatment durations for acute bacterial rhinosinusitis: Five days of gemifloxacin versus 7 days of gemifloxacin.
Otolaryngol Head Neck Surg
; 127(1): 1-6, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12161723
14.
Pharmacokinetics of dalbavancin in plasma and skin blister fluid.
J Antimicrob Chemother
; 60(3): 681-4, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17631507